Walter Low, Phd Email and Phone Number
Walter Low, Phd work email
- Valid
- Valid
- Valid
- Valid
Walter Low, Phd personal email
Over 20 years experience in the healthcare industry, successfully leading the development and launch of biological drugs from early-stage R&D and CMC to clinical trials, regulatory interactions, submissions and approvals (FDA, EMA, PMDA, Health Canada) culminating in global product launches. Backed by a strong scientific foundation, provide comprehensive oversight of all phases of drug development, ensuring compliance and market success.Extensive international experience managing complex, cross-functional teams and multi-site projects across diverse cultures. Known for driving high-performing teams, building strategic partnerships, and delivering projects on time, quality and within budget, with expertise in licensing and alliance partnerships.Expertise includes identifying risks, solving complex problems, mobilizing support, and facilitating clear, effective decision-making to ensure project momentum and success.
-
Owner And Managing DirectorDrosia Biopharma Consulting LtdLondon, Gb
-
Scientific Advisory Board MemberSpacepharma Jun 2024 - PresentCourgenay, Ch -
Board Of Trustees And Research Committee MemberMacular Society Jun 2024 - PresentAndover, Hampshire, Gb -
Owner & Managing DirectorDrosia Biopharma Consulting Ltd Aug 2024 - PresentStrategic and Operational Drug Development ConsultingCurrent projects include:- Strategic Lead for a biosimilar drug development program at a global pharmaceutical company, leading an international team and alliance partner to complete development activities and ensure a timely launch- Supporting a biotech startup with fundraising initiatives and planning efforts, including devising comprehensive antibody drug development strategies to accelerate product pipeline growth and attract investor engagement.
-
Vice President Program Head, Portfolio & Alliance ManagementAlvotech Jul 2020 - Jun 2024Reykjavik, -, IsAlvotech (NASDAQ: ALVO) is a fully integrated specialty multinational biopharmaceutical company focused on the development and manufacturing of high-quality biosimilar medicines for global markets. Alvotech operates across centres of excellence in Iceland, Germany, Switzerland and the United States. CAHT is the China joint venture company of Alvotech and Changchun High & New Technology Industries• Member of the Alvotech leadership team, providing overall strategic leadership & oversight for a portfolio of biosimilar development programs to global program teams. Program Head for AVT02 (biosimilar to Humira), AVT04 (biosimilar to Stelara) both achieving regulatory approval and launched globally and AVT03 (biosimilar to Prolia / Xgeva) and AVT23 (biosimilar to Xolair)• Lead multiple project teams of cross-functional experts spanning CMC, Pre-Clinical and Clinical Development, Regulatory Affairs, Quality, Finance, Intellectual Property across Europe, US, India, Australia and China. Accountable for programs milestones and deliverables.• Joint Development Working Groups and partaker to the Steering Committees for key development alliance partners, e.g. Fuji Pharma (JP), TEVA (US), STADA (EU), JAMP (CA) -
Global Program HeadPolpharma Biologics Jun 2019 - Jun 2020Gdańsk, Pomorskie, PlPolpharma Biologics is focused on the development and manufacturing of biosimilar and novel biologic drugs. Polpharma Biologics Group operates across centres of excellence in Poland, the Netherlands and Switzerland.Current position and responsibilities built up on previous role as Global Program Manager at bioeq GmbH which led to the successful advancement of Polpharma Biologics’ lead product, a biosimilar of natalizumab, from early CMC development to advanced clinical stages paving the way for a global commercialisation agreement with Sandoz (Novartis).• Member of Polpharma Biologics leadership team reporting to CEO and President of Management Board.• Lead, coordinate and control of global cross‐functional development teams and projects from early stage CMC development through to completion of Ph 1 and Ph 3 clinical studies and health authorities interactions.• Operations Committee and Steering Committee member providing review, guidance and oversight for overall operations of the global commercialisation agreement between Polpharma Biologics and Sandoz. -
Global Program HeadBioeq Gmbh (Polpharma Biologics / Strüngmann Group) Jun 2014 - Jun 2019bioeq GmbH is a joint venture between the Polpharma Biologics and the Strüngmann Family Office (Santo Holding) and active in the development of biosimilar drugs for global markets• Member of bioeq management board, reporting to CEO and steering committee • Overarching coordination, control and completion of global cross‐functional development projects in house, at contract service providers (CROs & CMOs) and in collaboration with other pharma and biotech companies • Lead cross-functional strategic and operational plans for a portfolio of biosimilar programs from early development stage into clinical trials
-
Director, Technology Development & Antibody EngineeringPx'Therapeutics Jan 2010 - May 2014PX’Therapeutics is a global orientated biopharmaceutical contract development and manufacturing organisation (CDMO), specialising in the development of therapeutic antibodies and proteins from early stage research up to clinical grade GMP manufacturing• Member of the senior management and executive board directly reporting to the CEO• Scientific Management responsibility for a multidisciplinary team of 14 at different locations
-
Assoc Director, Biologics DevelopmentPx'Therapeutics Feb 2008 - Jan 2010• Development and manufacturing of therapeutic antibodies and proteins from early stage R&D up to cGMP production for Ph I clinical trials• Responsibility for the planning and progression of customer projects and the management of daily operations within the Quality Control laboratories supporting the commercial and clinical product release
-
R&D DirectorMicrotest Matrices Ltd May 2004 - Jan 2008Microtest Diagnostics was spun out of Imperial College London with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease with a desktop device at the point of care• Reporting to CEO, design and development of protein and antibody microarrays for the identification and quantification of antibodies and biomarkers in human sera• Development of multiplex immunoassay-based bio chips, associated lateral flow device and optical reader for clinical diagnostic applications (i.e. autoimmune, allergy, infectious diseases)
-
Team Leader/Project ManagerBiogeny Plc Dec 2001 - Apr 2004An early stage biotechnology spin-off company from Imperial College London focused on the discovery and development of Protein Transduction Technology
Walter Low, Phd Skills
Walter Low, Phd Education Details
-
Imperial College LondonDepartment Of Biological Sciences -
UclImmunology And Gene Therapy
-
The Hebrew University Of JerusalemBiochemistry
Frequently Asked Questions about Walter Low, Phd
What company does Walter Low, Phd work for?
Walter Low, Phd works for Drosia Biopharma Consulting Ltd
What is Walter Low, Phd's role at the current company?
Walter Low, Phd's current role is Owner and Managing Director.
What is Walter Low, Phd's email address?
Walter Low, Phd's email address is wa****@****oeq.com
What schools did Walter Low, Phd attend?
Walter Low, Phd attended Imperial College London, Ucl, The Hebrew University Of Jerusalem.
What are some of Walter Low, Phd's interests?
Walter Low, Phd has interest in Children.
What skills is Walter Low, Phd known for?
Walter Low, Phd has skills like Biotechnology, Monoclonal Antibodies, Technology Transfer, Mammalian Cell Culture, Protein Chemistry, Biochemistry, R&d, High Throughput Screening, Protein Engineering, Antibodies, Immunology, Bioprocess.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial